Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Management of intraductal papillary mucinous tumours of the pancreas
Home
Publications
Management of intraductal papillary mucinous tumours of the pancreas
Management of intraductal papillary mucinous tumours of the pancreas
Francis Navarro
Francis Navarro
JM
Jacques Michel
Jacques Michel
PB
Paul Bauret
Paul Bauret
Jeanne Ramos
Jeanne Ramos
Pierre Blanc
Pierre Blanc
Jean Michel Fabre
Jean Michel Fabre
Bertrand Millat
Bertrand Millat
BD
Bruno Desrousseaux
Bruno Desrousseaux
JD
Jacques Domergue
Jacques Domergue
Publisher Website
Google Scholar
Cite
Download
Share
Download
1 February 1999
journal article
Published by
Oxford University Press (OUP)
in
British Journal of Surgery
Vol. 165
(1)
,
43-48
https://doi.org/10.1080/110241599750007496
Abstract
Objective: To focus attention on the management and outcome of patients with intraductal papillary mucinous tumours of the pancreas. Design: Retrospective study and analysis of published reports. Setting: University hospital, France. Subjects: 111 patients (101 published cases and our own 10 cases) divided in two groups: the first including malignant tumours (
n
= 46), and the second group benign or in situ tumours (
n
= 61). In 4 patients the type of tumour was not known. Main outcome measure: Resectability, mortality and recurrence. Results: More men had benign or in situ tumours [48/61 (79%) compared with 28/46 (61%),
p
= 0.054]. Pancreatitis was more common among benign than malignant tumours [34/61 (58%) compared with 21/46 (46%),
p
= 0.33]. In group I, 39 patients had diabetes. A total of 107 patients were operated on: pancreaticoduodenectomy (
n
= 54, 50%), distal pancreatectomy (
n
= 25, 23%), total pancreatectomy (
n
= 4, 4%), bypass (
n
= 2, 2%). The type of resection was not mentioned in 22 records (21%). Four patients were not operated on because of their poor general condition. The resectability rate was 98% (105/107). Eleven patients had died at the time of publication. Hospital mortality rate was 3% (
n
= 3), mainly because 2 of the 4 who had total pancreatectomy died. With a median follow‐up of 37 months, recurrence was 5% (
n
= 5). Conclusion: Intraductal papillary mucinous tumours of the pancreas are well known distinctive pancreatic tumours that are usually intraductal but may develop into invasive carcinoma. They should be resected, and have a good prognosis and low recurrence rate. Copyright © 1999 Taylor and Francis Ltd.
Keywords
DIABETES
PANCREAS
DIED
PUBLISHED
PAPILLARY MUCINOUS
INTRADUCTAL PAPILLARY
MUCINOUS TUMOURS
All Articles
Open Access
Cited by 31 articles